Literature DB >> 28538173

Cortico-Accumbens Regulation of Approach-Avoidance Behavior Is Modified by Experience and Chronic Pain.

Neil Schwartz1, Catriona Miller2, Howard L Fields2.   

Abstract

Although optimizing decisions between drives to avoid pain and to obtain reward are critical for survival, understanding the neuronal circuit activity that regulates choice during approach-avoidance conflicts is limited. Here, we recorded neuronal activity in the infralimbic (IL) cortex and nucleus accumbens (NAc) during an approach-avoidance task. In this task, disruption of approach by a pain-predictive cue (PPC-avoidance) is extinguished by experience and reinstated in a model of chronic pain. In the IL-NAc circuit, the activity of distinct subpopulations of neurons predicts the extent of PPC-avoidance observed. Furthermore, chemogenetic and optogenetic manipulations establish that IL-NAc circuitry regulates PPC-avoidance behavior. Our results indicate that IL-NAc circuitry is engaged during approach-avoidance conflicts, and modifications of this circuit by experience and chronic pain determine whether approach or avoidance occurs.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  accumbens; approach-avoidance; choice; chronic pain; infralimbic; motivation; pain; ventral striatum; vmPFC

Mesh:

Year:  2017        PMID: 28538173     DOI: 10.1016/j.celrep.2017.04.073

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  16 in total

1.  Human social defeat and approach-avoidance: Escalating social-evaluative threat and threat of aggression increases social avoidance.

Authors:  Michael W Schlund; Hannah Carter; Gloria Cudd; Katie Murphy; Nebil Ahmed; Simon Dymond; Erin B Tone
Journal:  J Exp Anal Behav       Date:  2020-12-28       Impact factor: 2.468

Review 2.  Peripheral and central viewpoints of chronic pain, and translational implications.

Authors:  A Vania Apkarian; Diane Reckziegel
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

3.  Neural Activity in Ventral Medial Prefrontal Cortex Is Modulated More Before Approach Than Avoidance During Reinforced and Extinction Trial Blocks.

Authors:  Ronny N Gentry; Matthew R Roesch
Journal:  J Neurosci       Date:  2018-04-16       Impact factor: 6.167

Review 4.  The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.

Authors:  Randal A Serafini; Kerri D Pryce; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2020-01-01       Impact factor: 13.382

5.  Pain-Evoked Reorganization in Functional Brain Networks.

Authors:  Weihao Zheng; Choong-Wan Woo; Zhijun Yao; Pavel Goldstein; Lauren Y Atlas; Mathieu Roy; Liane Schmidt; Anjali Krishnan; Marieke Jepma; Bin Hu; Tor D Wager
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

6.  Avoidance Problems Reconsidered.

Authors:  Christopher K Cain
Journal:  Curr Opin Behav Sci       Date:  2018-09-21

Review 7.  Modeling Pain Using fMRI: From Regions to Biomarkers.

Authors:  Marianne C Reddan; Tor D Wager
Journal:  Neurosci Bull       Date:  2017-06-23       Impact factor: 5.203

Review 8.  Brain circuits for pain and its treatment.

Authors:  Nicole Mercer Lindsay; Chong Chen; Gadi Gilam; Sean Mackey; Grégory Scherrer
Journal:  Sci Transl Med       Date:  2021-11-10       Impact factor: 17.956

9.  Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex.

Authors:  Edita Navratilova; Kelsey Nation; Bethany Remeniuk; Volker Neugebauer; Kirsty Bannister; Anthony H Dickenson; Frank Porreca
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

Review 10.  Reward Processing under Chronic Pain from the Perspective of "Liking" and "Wanting": A Narrative Review.

Authors:  Xinhe Liu; Ning Wang; Lijia Gu; Jianyou Guo; Jinyan Wang; Fei Luo
Journal:  Pain Res Manag       Date:  2019-04-21       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.